These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2936333)

  • 21. Polymorphism and proteolytic fragments of granulocyte membrane cofactor protein (MCP, CD46) of complement.
    Matsumoto M; Seya T; Nagasawa S
    Biochem J; 1992 Jan; 281 ( Pt 2)(Pt 2):493-9. PubMed ID: 1736895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of the epitope for the inhibitory monoclonal antibody 5-B6 on the catalytic subunit of gastric Mg(2+)-dependent H(+)-transporting and K(+)-stimulated ATPase.
    Van Uem TJ; Swarts HG; De Pont JJ
    Biochem J; 1991 Nov; 280 ( Pt 1)(Pt 1):243-8. PubMed ID: 1720615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolation, by partial pepsin digestion, of the three collagen-like regions present in subcomponent Clq of the first component of human complement.
    Reid KB
    Biochem J; 1976 Apr; 155(1):5-17. PubMed ID: 7240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Localization of a thrombin-binding site on human platelet membrane glycoprotein Ib determined by a monoclonal antibody.
    Yamamoto K; Yamamoto N; Kitagawa H; Tanoue K; Kosaki G; Yamazaki H
    Thromb Haemost; 1986 Apr; 55(2):162-7. PubMed ID: 2424116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neoantigens in complement component C3 as detected by monoclonal antibodies. Mapping of the recognized epitopes by synthetic peptides.
    Nilsson B; Nilsson Ekdahl K; Avila D; Nilsson UR; Lambris JD
    Biochem J; 1990 May; 268(1):55-61. PubMed ID: 1693076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Truncated forms of human complement factor H.
    Fontaine M; Demares MJ; Koistinen V; Day AJ; Davrinche C; Sim RB; Ripoche J
    Biochem J; 1989 Mar; 258(3):927-30. PubMed ID: 2525027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conformational differences between surface-bound and fluid-phase complement-component-C3 fragments. Epitope mapping by cDNA expression.
    Nilsson B; Grossberger D; Nilsson Ekdahl K; Riegert P; Becherer DJ; Nilsson UR; Lambris JD
    Biochem J; 1992 Mar; 282 ( Pt 3)(Pt 3):715-21. PubMed ID: 1372802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An amphiphilic structure of the ninth component of human complement. Evidence from analysis of fragments produced by alpha-thrombin.
    Biesecker G; Gerard C; Hugli TE
    J Biol Chem; 1982 Mar; 257(5):2584-90. PubMed ID: 6460761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An investigation of the interaction between human complement factor H and C3b.
    Soames CJ; Sim RB
    Biochem Soc Trans; 1995 Feb; 23(1):53S. PubMed ID: 7758768
    [No Abstract]   [Full Text] [Related]  

  • 30. Novel cleavage products of the third component of human complement.
    Harrison RA; Lachmann PJ
    Mol Immunol; 1980 Feb; 17(2):219-28. PubMed ID: 6993918
    [No Abstract]   [Full Text] [Related]  

  • 31. The identification of epitopic sites in human alpha 1-proteinase inhibitor.
    Zhu XJ; Kang SS; Hargrove K; Shochat D; Jarrells M; Mojesky M; Chan SK
    Biochem J; 1987 Aug; 246(1):25-36. PubMed ID: 2445337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A structural and functional analysis of the docking protein. Characterization of active domains by proteolysis and specific antibodies.
    Hortsch M; Avossa D; Meyer DI
    J Biol Chem; 1985 Aug; 260(16):9137-45. PubMed ID: 2410409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Probing functional sites on complement protein B with monoclonal antibodies. Evidence for C3b-binding sites on Ba.
    Ueda A; Kearney JF; Roux KH; Volanakis JE
    J Immunol; 1987 Feb; 138(4):1143-9. PubMed ID: 2433342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Large-scale isolation of complement receptor type 1 (CR1) from human erythrocytes. Proteolytic fragmentation studies.
    Sim RB
    Biochem J; 1985 Dec; 232(3):883-9. PubMed ID: 2936334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
    Camire RM; Kalafatis M; Tracy PB
    Biochemistry; 1998 Aug; 37(34):11896-906. PubMed ID: 9718313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunologically reactive tryptic fragments of human prostatic acid phosphatase.
    Lee CL; Li SS; Chu TM
    Biochem J; 1984 Nov; 223(3):871-7. PubMed ID: 6210078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cleavage of C4b by C3b inactivator: production of a nicked form of C4b, C4b', as an intermediate cleavage product of C4b by C3b inactivator.
    Nagasawa S; Ichihara C; Stroud RM
    J Immunol; 1980 Aug; 125(2):578-82. PubMed ID: 7391570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new cleavage site for elastase within the complement component 3.
    Claesson R; Kanasi E; Johansson A; Kalfas S
    APMIS; 2010 Oct; 118(10):765-8. PubMed ID: 20854470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Limited proteolysis of complement components C2 and factor B. Structural analogy and limited sequence homology.
    Kerr MA
    Biochem J; 1979 Dec; 183(3):615-22. PubMed ID: 261515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of complement-protein-C3b density on the binding of complement factor H to surface-bound C3b.
    Koistinen V
    Biochem J; 1991 Nov; 280 ( Pt 1)(Pt 1):255-9. PubMed ID: 1835839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.